human papillomavirus

The nine-valent HPV vaccine -- which targets nine different HPV strains -- could prevent about 3 in 4 HPV-associated cancers. However, only about half of all adolescents have completed the vaccine series. If everyone was fully vaccinated we could prevent some 32,100 cancers each year.
The American Cancer Society estimates that more than 13,000 cervical cancers will be diagnosed in 2018. Of those, more than 3,000 women will die.  Cervical cancers stem from the Human papillomavirus, a sexually transmitted infection. And it can be prevented with a cancer vaccine already in place. Yet, the rates of immunization among young adults are low.
Regardless of where one falls on the HPV vaccine debate, there's good news from Australia. New research shows that men who are unvaccinated for HPV are receiving protective benefits from the women who are vaccinated. 
When it comes to cancer, prevention is always preferred to diagnosis and treatment. Discuss HPV vaccination and your eligibility (as well as your kids' eligibility) with your doctor. A new study reveals poor vaccine rates and significant prevalence in males.  
Women's health
Roughly 1 in 3 women douche, but there is no good health reason to do so. Douching can change the makeup of the bacteria that normally live in the vagina, and it can even make women more susceptible to STDs. Now, researchers have added another concern: Douching appears to increase the risk of infection with HPV (human papillomavirus), which causes cervical cancer. 
New research found that a single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix) may offer a similar level of protection against the serotypes of HPV types 16 and 18, which cause 70 percent of cervical cancers as the current two and three dose schedules. The findings come from a new analysis of two large phase
Back in February, several prominent medical associations made a recommendation that the newly FDA approved HPV DNA test should replace pap smears or co-testing (pap smear and HPV assay) as the primary mechanism for detecting cervical cancer for all age groups.
A new study from Duke University found that encouraging more boys to get the HPV vaccine might provide greater overall protection with a better cost-benefit profile. The study was published in the journal Epidemics.
In December, we wrote about the FDA approval of Gardasil 9, which prevents approximately 90 percent of cervical,
HPV-vaccineThe human papillomavirus (HPV) vaccine protects against several major types of HPV, a causative factor for cervical cancer and genital warts. Although the vaccine is safe and effective, vaccination rates among American girls and
HPV (human papillomavirus), the most common sexually transmitted infection, can lead to several types of cancers, including cervical. About 79 million Americans are currently infected with HPV, and there are about 14 million new cases every year. The HPV vaccine protects against four major types of HPV, and can prevent most cases of cervical cancer (and likely other cancers as well, but those studies are only now underway), as well as genital warts.
The latest ACSH health headlines: The HPV vaccines works! And the U.S. has some catching up to do. What's bugging New Yorkers? Bed bugs of course, and ACSH's Dr. Josh Bloom's take on the matter appears in the Wall Street Journal. And yet another study showing the dangers of using herbal and dietary supplements- this time, liver damage.